Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthetic and medicinal perspective of quinolines as antiviral agents
Ramandeep Kaur, Kapil Kumar
European Journal of Medicinal Chemistry (2021) Vol. 215, pp. 113220-113220
Open Access | Times Cited: 145

Showing 1-25 of 145 citing articles:

A Review on Medicinally Important Heterocyclic Compounds
Tanzeela Qadir, Andleeb Amin, Praveen Kumar Sharma, et al.
The Open Medicinal Chemistry Journal (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 90
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 80
Promising Schiff bases in antiviral drug design and discovery
Shikha Kaushik, Sarvesh Paliwal, Malliga R. Iyer, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 6, pp. 1063-1076
Open Access | Times Cited: 60
Quinoline Hydrazide/Hydrazone Derivatives: Recent Insights on Antibacterial Activity and Mechanism of Action
Sangeeta Verma, Sukhbir Lal, Rakesh Narang, et al.
ChemMedChem (2023) Vol. 18, Iss. 5
Closed Access | Times Cited: 51
Pyridine Scaffolds, Phenols and Derivatives of Azo Moiety: Current Therapeutic Perspectives
Tehreem Tahir, Muhammad Ashfaq, Muhammad Saleem, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4872-4872
Open Access | Times Cited: 60
A Review of Modifications of Quinoline Antimalarials: Mefloquine and (hydroxy)Chloroquine
Dawid J. Kucharski, Michalina K. Jaszczak, Przemysław J. Boratyński
Molecules (2022) Vol. 27, Iss. 3, pp. 1003-1003
Open Access | Times Cited: 40
Recent developments in antimalarial activities of 4-aminoquinoline derivatives
Lekkala Ravindar, Siti Aishah Hasbullah, K.P. Rakesh, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115458-115458
Closed Access | Times Cited: 29
Design, synthesis, molecular docking, dynamics simulations and antiviral activities of quinoline derivatives
Vishal Singh, Shivangi Rai, Apoorva Singh Parihar, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139531-139531
Closed Access | Times Cited: 10
Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone derivatives
Jiaxing Lu, Hai-Rong Lan, Dai Zeng, et al.
RSC Advances (2025) Vol. 15, Iss. 1, pp. 231-243
Open Access | Times Cited: 1
Recent contributions of quinolines to antimalarial and anticancer drug discovery research
Tim Van de Walle, Lore Cools, Sven Mangelinckx, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113865-113865
Open Access | Times Cited: 54
Friedlӓnder's synthesis of quinolines as a pivotal step in the development of bioactive heterocyclic derivatives in the current era of medicinal chemistry
Rajendran Satheeshkumar, Kalaiselvi Sivalingam, Karnam Jayarampillai Rajendra Prasad, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 6, pp. 1042-1085
Closed Access | Times Cited: 32
Mono- and combinational drug therapies for global viral pandemic preparedness
Aleksandr Ianevski, Rouan Yao, Ronja M. Simonsen, et al.
iScience (2022) Vol. 25, Iss. 4, pp. 104112-104112
Open Access | Times Cited: 30
Quinolines and isoquinolines as HIV-1 inhibitors: Chemical structures, action targets, and biological activities
Sha Hu, Jiong Chen, Jin-Xu Cao, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106549-106549
Closed Access | Times Cited: 21
Quinoline Derivatives: Promising Antioxidants with Neuroprotective Potential
Luis Felipe Hernández‐Ayala, Eduardo Gabriel Guzmán‐López, Annia Galano
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1853-1853
Open Access | Times Cited: 16
Design, in silico studies and biological evaluation of novel chalcones tethered triazolo[3,4-a]isoquinoline as EGFR inhibitors targeting resistance in non-small cell lung cancer
Nesma Abdelaal, Mohamed A. Ragheb, Hamdi M. Hassaneen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Copper-catalyzed dehydrogenative cyclization/alkenylation towards dihydroquinolinones
K. Pari, Nawaz Khan Fazlur-Rahman
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 20, pp. 4163-4171
Closed Access | Times Cited: 6
Chemodynamic therapy agents Cu(II) complexes of quinoline derivatives induced ER stress and mitochondria-mediated apoptosis in SK-OV-3 cells
Wen-Ying Shen, Chun-Peng Jia, Anna Mo, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113636-113636
Closed Access | Times Cited: 35
Synthesis and biological evaluation of new 2‑substituted‑4‑amino-quinolines and -quinazoline as potential antifungal agents
Tianhong Qin, Jianchuan Liu, Jinyuan Zhang, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 72, pp. 128877-128877
Closed Access | Times Cited: 27
Ultrasound promoted synthesis of new azo fused dihydropyrano[2,3-c]pyrazole derivatives: In vitro antimicrobial, anticancer, DFT, in silico ADMET and Molecular docking studies.
N. Nagasundaram, Kannayiram Padmasree, Santhosh Sigamani, et al.
Journal of Molecular Structure (2022) Vol. 1263, pp. 133091-133091
Closed Access | Times Cited: 26
The anti-HIV potential of imidazole, oxazole and thiazole hybrids: A mini-review
Cui Deng, Heng Yan, Jun Wang, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 11, pp. 104242-104242
Open Access | Times Cited: 24
Synthesis of a novel chloroquinoline, rhodanine encompassed 1,2,3-triazole scaffolds and molecular docking evaluation of their cytotoxicity
Kotyada Suryanarayana, Kranthi Kumar Gangu, Nagaraju Kerru, et al.
Journal of the Iranian Chemical Society (2023) Vol. 20, Iss. 10, pp. 2643-2655
Open Access | Times Cited: 15
Current progress toward synthetic routes and medicinal significance of quinoline
Wesam S. Shehab, Mostafa M. Amer, Doaa A. Elsayed, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 12, pp. 2443-2457
Open Access | Times Cited: 13
Novel quinoline derivatives with broad‐spectrum antiprotozoal activities
Carla B. Hartman, Phelelisiwe S. Dube, Lesetja J. Legoabe, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 6
Open Access | Times Cited: 5
Harnessing molecular hybridization approach to discover novel quinoline EGFR-TK inhibitors for cancer treatment
Noha Ryad, Ayman Abo Elmaaty, Ibrahim M. Ibrahim, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 11, pp. 1087-1107
Closed Access | Times Cited: 5
Cytotoxic Cu(II) Complexes with a Novel Quinoline Derivative Ligand: Synthesis, Molecular Docking, and Biological Activity Analysis
Gemechu Shumi, Taye B. Demissie, Moses O. Koobotse, et al.
ACS Omega (2024) Vol. 9, Iss. 23, pp. 25014-25026
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top